Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04827524
Other study ID # Craniosynostosis
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2020
Est. completion date April 30, 2021

Study information

Verified date July 2021
Source Yuksek Ihtisas University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Craniosynostosis is a malformation affecting the head and face, in which one or more sutures in the skull are fused prematurely. Premature union of one or more sutures causes changes in the shape of the skull base and dome, resulting in asymmetrical or restricted head and facial enlargement. It has been reported that in craniosynostosis, the bone enlargement is perpendicular to the fused sutures with the counterbalancing expansion. Craniosynostosis usually involves the union of a single cranial suture, but in some cases it has been observed that it may involve more than one suture in the baby's skull. An asymmetrical appearance is observed on the faces of babies, especially an unusual appearance in the form of eyes and skulls. It may present with neurological defects such as hydrocephalus, mental retardation, vision and hearing loss, as well as cosmetic deformities in the skull and facial bones. The general prevalence of craniosynostosis is around 1/2500 births. Generally, in single suture synostoses, there is no clear neurological finding except deformity. In multisuture synostoses there are a wide spectrum of findings such as increased intracranial pressure, hydrocephalus, syringomyelia, Chiari malformation, venous anomalies, ophthalmologic problems, growth retardation and epilepsy. Early diagnosis and treatment provides enough room for the baby's brain to grow and develop. It is thought that by measuring the anthropometric properties of these babies, the course of their development will be examined.


Description:

Babies diagnosed with craniosynostosis at birth will be included in this study. The patients will be diagnosed using a combination of physical examination, skull radiographs and 3 dimensional computerized tomography scans.A voluntary consent form will be signed by the parents of all subjects indicating that they are willing to participate in the study. Anthropometric measurements of all subjects will be measured with the Star Scanner device.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date April 30, 2021
Est. primary completion date March 30, 2021
Accepts healthy volunteers No
Gender All
Age group 1 Month to 2 Years
Eligibility Inclusion Criteria: - Being under 2 years old - Being diagnosed with non-syndromic craniosynostosis - Agreeing to participate in the study Exclusion Criteria: - Having a craniomaxillofacial fracture - Having a history of surgery - Having a congenital anomaly that affects growth or development

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Anthropometric measurement
The demographic information and birth histories of the subjects included in the study will be taken first. Anthropometric measurements of all subjects will be measured with the Star Scanner device. The Star Scanner 3 dimensional data collection system is a scanning system that enables the anthropometric head measurements of the baby to be taken in just 2 seconds. The advantages of this device is that it does not emit any harmful beams during evaluation, it does not have any harmful effects on health, and that it is an application that will not disturb babies.

Locations

Country Name City State
Turkey Yuksek Ihtisas University Ankara Çankaya

Sponsors (1)

Lead Sponsor Collaborator
Yuksek Ihtisas University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary 3 dimensional anthropometric analysis of the cranium The 3 dimensional anthropometric analysis of the subjects cranium wil be measured using the Star Scanner device. Change from baseline anthropometric measure at 3 months.
See also
  Status Clinical Trial Phase
Recruiting NCT04159675 - Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts
Not yet recruiting NCT05511168 - Craniosynostosis :Surgical Treatment Modalities and Outcome N/A
Recruiting NCT04695938 - Craniofacial Imaging With 3D MRI: an Alternative to Ionising Radiation N/A
Recruiting NCT04072783 - Neurodevelopmental Outcomes in Craniosynostosis Repair N/A
Suspended NCT01094977 - Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid Phase 3
Completed NCT04086056 - CraNIRS Clinical Study
Withdrawn NCT03812159 - Clinical Feasibility Study of Preoperative Surgical Planning N/A
Completed NCT04133467 - Scalp Block Decreases Pain and Side Effects
Terminated NCT03698838 - Myelin Imaging Changes In Patients With Neurosurgical Diseases
Recruiting NCT06263075 - Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM)
Not yet recruiting NCT06366178 - EPBONF : Evaluation of the Safety and Effectiveness of a Medical Device Aimed at Guiding Orbito-naso-frontal Band Surgery, for the Treatment of Craniostenoses N/A
Completed NCT03915587 - Bedside Resources to Gauge Intravascular Volume Status N/A